Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 1, 2007 - Issue 3
Submit an article Journal homepage
62
Views
1
CrossRef citations to date
0
Altmetric
Review

90Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin’s lymphoma: current status and future prospects

Samuel A JacobsUniversity of Pittsburgh School of Medicine, 5150 Centre Avenue, Pittsburgh, PA, USACorrespondence[email protected]
Pages 215-227 | Published online: 07 Dec 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.